Speaking at the SIGMA Conference 2023, Dr Leyla Hannbeck, CEO of the Association of Independent Multiple Pharmacies (AIMp), spoke about the increasing
number of prescriptions, lack of funding and other existing challenges.
Leyla explained how the pharmacy sector is facing immense challenges which are disrupting the delivery of services as well as impacting its growth.
She further spoke about the hub and spoke model, and how it is unable to solve the issues.
"Community pharmacies are clogged with prescription volume, and this is preventing them from supporting the wider NHS as well as offering services," she said.
She said that the prescription volumes have rocketed, while the number of pharmacies in England has declined from 11, 522 in the year 2021-22 to 11, 414 in 2022-23.
When it comes to Company Chemists' Association (CCA) pharmacies, there has been a loss of 1055 branches from 2022 to 2023.
Pharmacists in the UK are reporting significant shortages of a common antibiotic used to treat whooping cough (pertussis), amid rising cases of this bacterial
infection.
Dr. Leyla Hannbeck, chief executive of the Independent Pharmacies Association (IPA), told BBC Radio 4's Today programme that clarithromycin, one of the key
antibiotics for treating whooping cough in children, is "completely out of stock."
Clarithromycin is an antibiotic commonly recommended for babies and infants under the age of 1 month.
Dr. Leyla said that as pharmacies cannot get the antibiotic, they are being forced to turn patients away or send them back to their doctors to have their
prescriptions changed to azithromycin or other antibiotics for treating whooping cough.
Community Pharmacy England, Company Chemists Association, and the National Pharmacy Association have all expressed their disappointment at a recent press
statement made by Dr Leyla Hannbeck, Chief Executive of the Association of Independent Multiple Pharmacies.
The CPE, CCA and NPA refuted AIMp's claim that pharmacy bodies operate independently, emphasising the importance of employing various channels and strategies
to shape public policy.
"It makes sense to use a variety of channels and tactics to influence public policy," NPA, CPE and CCA said in a joint statement issued on Wednesday (August 13).
"Limiting our work to just one Parliamentary channel would be naive and do a disservice to pharmacy owners."
On Aug. 12, AIMp highlighted that a lack of cohesion was one of the contributing factors to the sector's difficulty in gaining wider attention.
Dr. Hannbeck argued that it's counterproductive for each pharmacy organisation to maintain its own manifesto, essentially a lengthy wish-list that is often
unrealistic and unattainable. "This can conveniently allow those in power to easily employ a divide-and-conquer strategy," she said.
The Association of Independent Multiple Pharmacies (AIMP)'s members are not going to abandon the dosettes boxes, the association has announced. Instead, it
insisted that this service should be properly funded.
The association has emphasised on the importance of the service provided by pharmacists to elderly patients living independently.
Dr Leyla Hannbeck, chief executive of AIMP, said it was vital that patients for whom this service is suitable can continue accessing it and that it is properly
funded.
Blister pack trays or dosettes assist thousands of people across the UK in living independently and remaining in their own homes for longer.
"This is largely attributable to the care and professionalism shown by local pharmacies," said Hannbeck.
"Our members, as independent family-owned pharmacies, are not going to abandon this service for patients."
The Association of Independent Multiple Pharmacies (AIMp) has called upon all pharmacy organisations to unite and collectively represent the sector. While
underlining the need for the sector to adopt a straightforward manifesto that can be presented to the public, politicians, and decision-makers, the association
also advocated for a revitalisation of the 'Save Our Pharmacies' campaign, injecting it with renewed energy and a stronger sense of purpose.
AIMp pointed out that a lack of cohesion is one of the factors contributing to the sector's struggle in gaining attention. "The current trajectory of community
pharmacy is unsustainable," said Dr. Leyla Hannbeck, Chief Executive of AIMp. "To tackle the significant challenges ahead, we must work together cohesively. The
most effective approach is to actively engage with Parliament, leveraging politicians from across the political spectrum to advocate for our cause."
Meanwhile, the association urged various pharmacy bodies to unite in support of the Pharmacy All Party Parliamentary Group (APPG) to enhance its effectiveness
and broaden its influence, rather than working independently.
The Association of Independent Multiple Pharmacies (AIMp) and senior official of NHS Property Services (NHSPS) had a meeting on August 18 to review the rent
policy for health centre pharmacies.
Earlier, the association had sent a letter to NHSPS that was signed by pharmacies from across the sector, including single independents, pharmacy groups and members
of the Company Chemists' Association.
The letter outlined concerns about rent reviews and the impact of it on the co-located health centre pharmacies.
Dr Leyla Hannbeck, CEO of AIMp, said: "We outlined that whilst in the past, the norm established by the industry, was to base rents for co-located pharmacies
primarily based on patient list size, (and taking account of a few other factors), the industry now needs to revise the basis on which rents are determined for
co-located pharmacies."
The association, on behalf of the pharmacy sector, met the CEO of NHSPS and two of their senior directors (director or property management and their finance director).
Lack of appropriate funding is making survival a massive challenge for community pharmacy, a sector relied upon as a vital support system by both primary and
secondary care in England.
The Telegraph newspaper ran a story on Monday (August 22) which highlighted the dire straits community pharmacy finds itself in. Seasoned pharmacist Ian Strachan
told the paper: "Our four pharmacies were the only point of call that was open (during Covid). We were there every single day, even when the virus was prevalent and
people were dying."
Describing the current situation, he said: "What is happening is we're facing a system that's just not working at all in our favour." Strachan says the issue is that
pharmacists are "just not getting the help we need to be able to do this job properly".
The sector is hugely dependent on funding from the NHS. The government had agreed in 2019 to set £2.6bn as annual funding for the sector. However, according to a
report from EY that amount was already down £200m on the 2016 levels of government funding.
"We've been starved of appropriate funding since 2016," Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies told The Telegraph.
"It looks grim for businesses. The fees pharmacists get are going nowhere, but now, there's higher utility bills, higher staff fees and higher drug costs."
Increased demand and shortages of lateral flow tests are pushing staff at pharmacies to bear the brunt from frustrated customers who are unable to get their free lateral flow tests, Daily Mail reported.
Some Britons claimed that they have been unable to get lateral flow tests at their local pharmacies for up to a fortnight while some pharmacies were forced to put up sign warning stating they have run out of free tests.
Given the patchy supply of test kits, pharmacy bosses warned that staff are facing 'unfair' and 'abusive' behaviour by customers, the newspaper reported.Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies (AIMP), told the newspaper: "Up until yesterday the supply to pharmacies was still patchy. The past few days the situation has not improved.
"Pharmacies are having to put up with a lot of abuse and aggressive behaviours by members of the public because of this situation which is unfair.
"The demand is still very high now because the governments guidelines put a lot of emphasis on testing as a key out of self isolation, so naturally as Omicron cases are high people are reliant on tests to get on with daily life."
"If the Government does not support community pharmacies with the relevant funding, then we will see a massive number of closures," warns Dr. Leyla Hannbeck,
chief executive of the Independent Pharmacies Association (IPA).
The Fight4Pharmacies campaign, led by the IPA, is urging prime minister Rishi Sunak to address a critical £1.2 billion funding shortfall that threatens the survival
of independent pharmacies across the UK.
This urgent plea comes as 1,000 community pharmacies have closed since 2019 due to rising operational costs and insufficient reimbursements.
On May 21, supporters of the Fight4Pharmacies campaign, along with 50 MPs including prominent figures like Priti Patel and Gavin Williamson, delivered a petition
to Downing Street.
The petition, Prescription to Save Our Pharmacies outlines how independent community pharmacies can be supported to ensure smooth running of pharmacies.
Anyone who has studied the finances of an independent pharmacy business knows that money is tight. In many cases, they are perilously close to failure.
It's easy to assume they are retail businesses, cashing in on the higher public profile the sector has enjoyed during the pandemic years. But those have been mere
words. Certainly, the pandemic represented a halcyon period for the profession.
We engendered a feeling of normality, dependable and accessible to society. We played a substantive role in keeping people out of hospitals and giving the vulnerable
the ability to live independently from their own homes for longer. We mobilised to smash flu vaccination records and deliver covid jabs.
But despite the warm words of a new service based future and the incessant expressions of gratitude contractors desperately need the headroom to prepare, plan and
invest. Platitudes, press releases and assurances of a bright clinical future are small comfort to what is needed and that's cash on the table. As the adage goes:
"Talk is cheap, money buys houses."
Cashflow crisis
Since 2016, we have witnessed almost 650 pharmacies fall by the wayside. Some may have merged; the majority, however, have perished due to the relentless need for an
increasing cashflow. It is cash, or rather the lack of it, which is killing independent pharmacies.
The recent announcement that Royal Mail will be partnering with distance selling pharmacy (DSP) giant pharmacy2U highlights how standards of regulatory
enforcement are being ignored to accommodate the DSP model.
The brunt of these double standards hinges around the levelling down of temperature enforcement standards by the Medicines and Healthcare products Regulatory
Agency (MHRA) which demands mapping must be audited from the point of dispensing to the patient.
The MHRA has a well recognised duty to ensure medicines reach patients in a safe condition. The current anomaly appears to turn a blind eye to this step in the
supply chain at the point the wholesaler releases goods to the pharmacy hub.
Equally the training on delivering medicines safely and effectively direct to patients should apply fully to all hubs including DSPs. Why is it that DSPs are being
treated differently to bricks and mortar pharmacies? It's essentially the same patients receiving the same medicines from the same wholesalers.
A further regulatory disparity exists around how parcels must be "tracked and signed for" to be reasonably certain medicines are delivered into the hand of the
intended recipient, as per existing regulations.
Clearly an untracked, unsigned package cannot be guaranteed to finish in the hands of the intended recipient.
There is a very real possibility that such omission could lead to community pharmacy closures which will, in turn, lead to unemployment and a reduction in the
care services. At a time when integrated care systems have just gone live, the removal of vital support services leading to further inequalities is the wrong
message for both providers and patients alike.